Acute Phase Proteins as Early Markers in Sepsis
- Conditions
- Sepsis
- Registration Number
- NCT00641355
- Lead Sponsor
- University of Zurich
- Brief Summary
Monitoring of different serumproteins after severe trauma and during trauma-induced sepsis.
* Trial with surgical intervention
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What role do acute phase proteins play in trauma-induced sepsis pathophysiology?
How do acute phase proteins compare to traditional biomarkers like CRP in sepsis detection?
What are the key molecular pathways regulated by acute phase proteins in sepsis progression?
Can acute phase proteins serve as predictive biomarkers for sepsis outcomes in trauma patients?
What adverse events are associated with elevated acute phase proteins in sepsis management?